How it works, simply
After an initial stimulation, continued signaling suppresses the release of reproductive hormones.
What the evidence tells us
This is not a fertility or hormone-optimization recommendation; the exact formulation and indication matter.
Watch with PEP 7
A short introduction; the sources and limitations remain important.
Open video guide
Video guides are coming soon.
Risks and open questions
- An initial hormone surge may worsen symptoms in certain patients.
- Metabolic changes and cardiovascular risks require product-specific review.
Research and education only. PepGuide does not recommend medicines, doses or protocols.
Technical details and study context
Mechanism: Chronic GnRH receptor stimulation suppresses gonadotropin signaling after an initial stimulation phase.
Sponsor or developer: Multiple manufacturers
Studied or labeled topics: Prostate cancer, Endometriosis, Central precocious puberty
Commercial blend names and research vials do not inherit a medicine’s approval or manufacturing controls.
Sources and review dates
- DailyMed: LUPRON DEPOT prescribing information ↗ · Regulator · Jun 18, 2026
Product labels and further research
These directories help locate records. They are not individual studies supporting every statement.
Readability updated October 10, 2026. Evidence review: October 10, 2026 (linked label: purpose and selected risks). A wording update is not a new clinical review.